Rockefeller Capital Management
PASG icon

Rockefeller Capital Management’s Passage Bio PASG Stock Holding History

Rockefeller Capital Management’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.28K Buy
800
+300
+60% +$3.1K ﹤0.01% 4178
2025
Q4 		$5.9K Buy
+500
New +$4.32K ﹤0.01% 4016
2021
Q2 		– Sell
-379
Closed -$132K – 3561
2021
Q1 		$132K Sell
379
-8
-2% -$3.42K ﹤0.01% 1493
2020
Q4 		$197K Hold
387
– – ﹤0.01% 1197
2020
Q3 		$101K Buy
387
+161
+71% +$55.4K ﹤0.01% 1250
2020
Q2 		$124K Buy
+226
New +$102K ﹤0.01% 1094

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rockefeller Capital Management's PASG Position: Q1 2026 in Review

Rockefeller Capital Management increased its Passage Bio (PASG) stake by 60% in Q1 2026, buying an estimated $3.1K and bringing the position to 800 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #4178.

Rockefeller Capital Management first reported a position in PASG in Q2 2020 and has held it in 6 quarters since. The position peaked at $197K in Q4 2020. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • Rockefeller Capital Management held 800 shares of Passage Bio worth $6.28K as of Q1 2026.
  • Rockefeller Capital Management bought 300 Passage Bio shares in Q1 2026, an estimated $3.1K.
  • Passage Bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4178 holding.
  • Rockefeller Capital Management first reported a position in Passage Bio in Q2 2020 and has held it in 6 quarters since.
  • Rockefeller Capital Management's Passage Bio position peaked at $197K in Q4 2020.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.